Diagnosis and Treatment of Neurocysticercosis: 2017 Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)
- PMID: 29617787
- PMCID: PMC5889044
- DOI: 10.1093/cid/ciy157
Diagnosis and Treatment of Neurocysticercosis: 2017 Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)
Figures
Comment in
-
Pregnancy Screening and Monitoring of Albendazole Therapy for Neurocysticercosis.Clin Infect Dis. 2018 Nov 13;67(11):1797-1798. doi: 10.1093/cid/ciy436. Clin Infect Dis. 2018. PMID: 29790912 No abstract available.
-
Diagnosis and Treatment of Neurocysticercosis: Issues That Need to Be Addressed.Clin Infect Dis. 2018 Nov 13;67(11):1796-1797. doi: 10.1093/cid/ciy434. Clin Infect Dis. 2018. PMID: 29790916 No abstract available.
-
Reply to Garg et al, Smith et al, and Persichino and Miller.Clin Infect Dis. 2018 Nov 13;67(11):1798. doi: 10.1093/cid/ciy437. Clin Infect Dis. 2018. PMID: 29790917 Free PMC article. No abstract available.
-
Antiparasitic Dosing Discrepancy in the 2017 Neurocysticercosis Guidelines.Clin Infect Dis. 2018 Nov 13;67(11):1797. doi: 10.1093/cid/ciy435. Clin Infect Dis. 2018. PMID: 29790919 No abstract available.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
